Warfarin and bone: implications for rational strategies to selectively antagonize the action of vitamin K in target tissues.
D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors; D001842:Bone and Bones / Q000187:drug effects*; D002135:Calcium-Binding Proteins / Q000502:physiology*; D006882:Hydroxyapatites / Q000378:metabolism; D015675:Osteocalcin; D011485:Protein Binding / Q000187:drug effects; D014812:Vitamin K / Q000502:physiology*; D014859:Warfarin / Q000494:pharmacology*
D001779:Blood Coagulation Factors; D002135:Calcium-Binding Proteins; D006882:Hydroxyapatites; D015675:Osteocalcin; D014812:Vitamin K; D014859:Warfarin